Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins

Area of Science:

• Immunology
• Allergy Research
• Cellular Biology

Background:

• Aberrant mast cell responses and complement activation are key in allergic diseases.
• Mast cells are sensitive to complement anaphylatoxins (C3a, C5a) and Interleukin-33 (IL-33).

Purpose of the Study:

• To investigate differential activation of human mast cells by C3a and C5a.
• To determine if IL-33 modulates mast cell responses to C3a and C5a.

Main Methods:

• Primary human mast cells were generated and stimulated.
• Assessed complement receptor expression, degranulation, mediator release, and intracellular signaling (phosphorylation, calcium flux).

Main Results:

• Human mast cells express higher C3aR1 than C5aR1; both receptors are downregulated by anaphylatoxins.
• C3a is a potent degranulation inducer, while C5a has weaker, delayed effects.
• IL-33 significantly enhances mast cell reactivity to C3a and C5a, mediated by intracellular signaling pathways like ERK1/2 phosphorylation.

Conclusions:

• Human mast cells exhibit differential responses to C3a and C5a.
• IL-33 is a critical regulator of mast cell responses to complement anaphylatoxins.
• This cross-regulation may exacerbate Th2 immune responses, suggesting anti-IL-33 therapies for allergic diseases.